SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-07-006697
Filing Date
2007-05-03
Accepted
2007-05-03 16:33:23
Documents
12
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c14755e10vq.htm 10-Q 231576
2 2002 LILLY STOCK PLAN, AS AMENDED c14755exv10w1.htm EX-10.1 57006
3 FORM OF SHAREHOLDER VALUE AWARD c14755exv10w2.htm EX-10.2 55602
4 STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE c14755exv11.htm EX-11 7775
5 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES c14755exv12.htm EX-12 9403
6 RULE 13A-14(A) CERTIFICATION OF SIDNEY TAUREL, CHAIRMAN OF THE BOARD AND CEO c14755exv31w1.htm EX-31.1 9441
7 RULE 13A-14(A) CERTIFICATION OF DERICA W. RICE, SENIOR VICE PRESIDENT AND CFO c14755exv31w2.htm EX-31.2 9445
8 SECTION 1350 CERTIFICATION c14755exv32.htm EX-32 3177
9 GRAPHIC c14755c1475501.gif GRAPHIC 9622
10 GRAPHIC c14755c1475500.gif GRAPHIC 9165
11 GRAPHIC c14755c1475502.gif GRAPHIC 3364
12 GRAPHIC c14755c1475503.gif GRAPHIC 1175
  Complete submission text file 0000950137-07-006697.txt   417613
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 07815986
SIC: 2834 Pharmaceutical Preparations